Roscoe Moore - Global Medical Independent Director
| GMRE Stock | USD 8.70 0.03 0.34% |
Director
Dr. Roscoe Moore Jr., Ph.D. is Director of the Company. Until his retirement in 2003, Dr. Roscoe M. Moore, Jr. served with the United States Department of Health and Human Services and was responsible for the last twelve years of his career for global development support within the Office of the Secretary, HHS, with primary emphasis on Continental Africa and other less developed countries of the world. Dr. Moore was a career officer within the Commissioned Corporationration of the United States Public Health Service entering with the U.S. National Institutes of Health and rising to the rank of Assistant United States Surgeon General within the Immediate Office of the Secretary, HHS. Dr. Moore served as an Epidemic Intelligence Service Officer with the U.S. Centers for Disease Control and Prevention . He was with the Center for Veterinary Medicine, U.S. Food and Drug Administration, before becoming Senior Epidemiologist within the National Institute for Occupational Safety and Health, CDC. Dr. Moore served on the Fogarty International Center Advisory Board of Directors, NIH from 2009 to2013. He served on the Alumni Board of Directors, School of Public Health, University of Michigan. Dr. Moore served on the Dean Alumni Council, Bloomberg School of Public Health, at Johns Hopkins University since 2015.
| Age | 76 |
| Tenure | 9 years |
| Address | 7373 Wisconsin Avenue, Bethesda, MD, United States, 20814 |
| Phone | 202 524 6851 |
| Web | https://www.globalmedicalreit.com |
Roscoe Moore Latest Insider Activity
Tracking and analyzing the buying and selling activities of Roscoe Moore against Global Medical stock is an integral part of due diligence when investing in Global Medical. Roscoe Moore insider activity provides valuable insight into whether Global Medical is net buyers or sellers over its current business cycle. Note, Global Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Global Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Roscoe Moore over six months ago Acquisition by Roscoe Moore of 5000 shares of Global Medical subject to Rule 16b-3 |
Global Medical Management Efficiency
The company has return on total asset (ROA) of 0.0171 % which means that it generated a profit of $0.0171 on every $100 spent on assets. This is way below average. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.02, whereas Return On Equity is forecasted to decline to 0.03. At present, Global Medical's Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 71 M, whereas Non Currrent Assets Other are projected to grow to (424.6 K).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Dana Hambly | National Health Investors | N/A | |
| Robert McCabe | National Health Investors | 70 | |
| James Jobe | National Health Investors | 59 | |
| Matthew Lustig | Ventas Inc | 59 | |
| Richard Gilchrist | Ventas Inc | 74 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Charlotte Swafford | National Health Investors | 73 | |
| Alan Gardner | Community Healthcare Trust | 67 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Robert Adams | National Health Investors | 74 | |
| Claire Gulmi | Community Healthcare Trust | 67 | |
| Kevin Jacobs | Omega Healthcare Investors | 47 | |
| Barbara Hill | Omega Healthcare Investors | 67 | |
| Kapila Anand | Omega Healthcare Investors | 67 | |
| Melody Barnes | Ventas Inc | 56 | |
| Robert Webb | National Health Investors | 76 | |
| John Abbott | Healthcare Realty Trust | 66 | |
| Walter Rakowich | Ventas Inc | 63 | |
| James Shelton | Ventas Inc | 66 | |
| James Morey | Universal Health Realty | 52 | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
Management Performance
| Return On Equity | 0.0072 | ||||
| Return On Asset | 0.0171 |
Global Medical REIT Leadership Team
Elected by the shareholders, the Global Medical's board of directors comprises two types of representatives: Global Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Medical's management team and ensure that shareholders' interests are well served. Global Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henry Cole, Lead Independent Director | ||
| Matthew Cypher, Independent Director | ||
| Robert CPA, CFO Treasurer | ||
| Robert Kiernan, Chief Financial Officer, Treasurer | ||
| Jingguo Zhang, Director | ||
| Huiqi Zhang, Director | ||
| Jamie Barber, General Counsel, Secretary | ||
| Roscoe Moore, Independent Director | ||
| Stephen Swett, Investor Executive | ||
| Ronald Marston, Independent Director | ||
| Jeffery Busch, President Chairman | ||
| Jeffrey JD, President Chairman | ||
| Lori Wittman, Independent Director | ||
| Paula Crowley, Independent Director | ||
| Danica Holley, Chief Operating Officer | ||
| Mary Jensen, Investor Professional | ||
| Alfonzo Leon, Chief Investment Officer | ||
| Allen Webb, Senior Vice President - SEC Reporting and Technical Accounting | ||
| Jeffrey Busch, Chairman of the Board , President , Chief Executive Officer |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Global Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0072 | ||||
| Return On Asset | 0.0171 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 66.8 M | ||||
| Shares Owned By Insiders | 5.65 % | ||||
| Shares Owned By Institutions | 62.99 % | ||||
| Number Of Shares Shorted | 1.2 M | ||||
| Price To Earning | 39.78 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.84 | Earnings Share (0.02) | Revenue Per Share 2.082 | Quarterly Revenue Growth (0.04) |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.